Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site

Linda Uttley1, Anand Vardhan, Sundeep Mahajan

  • 1Department of Renal Medicine, Manchester Royal Infirmary, Manchester, UK. ram.gokal@cmmc.nhs.uk

Journal of Nephrology
|August 6, 2004
PubMed
Abstract

Insights

Mupirocin cream significantly reduced Staphylococcus aureus exit site infections (ESI) and related peritonitis in peritoneal dialysis patients. This intervention offers a safe and effective strategy to prevent these common complications, improving patient outcomes.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Medical Microbiology

Background:

  • Staphylococcus aureus infections, including peritonitis and catheter exit site infections (ESI), are major causes of hospitalization and catheter loss in patients undergoing chronic peritoneal dialysis (PD).
  • Effective prevention strategies are crucial to improve patient outcomes and reduce healthcare burden associated with PD-related infections.

Purpose of the Study:

  • To evaluate the effectiveness of mupirocin cream applied to the catheter exit site in preventing ESI and peritonitis in PD patients.
  • To assess the impact of mupirocin on Staphylococcus aureus-related infections specifically.

Main Methods:

  • A prospective, historically controlled study involving 86 patients initiating a PD program.
  • Patients applied mupirocin cream 2% to the exit site daily or every other day.
  • A historical control group of 113 PD patients predating the intervention was used for comparison over a 22-month follow-up period.

Main Results:

  • Mupirocin application led to a significant reduction in overall ESI incidence (79% relative reduction) and Staphylococcus aureus ESI (85% relative reduction).
  • While overall peritonitis rates did not change, Staphylococcus aureus peritonitis significantly decreased (from 0.07 to 0 incidence).
  • Catheter removal rates were lower in the mupirocin group (1 vs. 5), though not statistically significant.

Conclusions:

  • Topical mupirocin application at the exit site is effective in significantly reducing the incidence of Staphylococcus aureus-related ESI and peritonitis in PD patients.
  • The intervention demonstrated a favorable safety profile with no significant side effects reported.

Related Concept Videos

Hand hygiene01:23

Hand hygiene

Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...